Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Zacks Investment Research Inc.
Provider: Thomson Reuters Stock Report
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Regado Biosciences Inc announces pricing of public offering of common stock

Friday, 11 Apr 2014 07:30am EDT 

Regado Biosciences Inc:Prices underwritten public offering of 10,000,000 shares of its common stock.Offered at a price of $6.00 per share to the public.Gross proceeds are expected to be about $60.0 mln.Offering is expected to close on or about April 16.Expects to use the net proceeds to fund further clinical development of its lead product candidate, REG1, and for working capital and other general corporate purposes.Jefferies LLC, Deutsche Bank Securities and Cowen and Company, LLC, are acting as joint book-running managers for the proposed offering. 

Company Quote

-0.02 -1.92%
31 Oct 2014